Rockwell Medical Q4 Earnings Preview

Rockwell Medical RMTI announces its next round of earnings Thursday. Here's Benzinga's advanced look at Rockwell Medical's Q4 earnings report.

Earnings and Revenue

Rockwell Medical EPS loss is expected to be around 13 cents, according to sell-side analysts. Sales will likely be near $13.8 million.

In the same quarter last year, Rockwell Medical posted a loss of 10 cents on sales of $13.3 million. If the company were to match the consensus estimate, earnings would be down 30 percent. Revenue would be have grown 3.06 percent from the same quarter last year.

Rockwell Medical's reported EPS has stacked up against analyst estimates in the past like this:

Stock Performance

Over the last 52-week period, shares are up 23.13 percent. Given that these returns are generally positive, long-term shareholders should be content going into this earnings release.

Analyst estimates are adjusted lower for EPS and revenues over the past 90 days. The popular rating by analysts on Rockwell Medical stock is a Neutral. The strength of this rating has maintained conviction over the past 90 days.

Conference Call

Rockwell Medical's Q4 conference call is scheduled to begin at 4:30 p.m. ET and can be accessed here.